Accordingly, the expression of phosphorylated ERK1/2 and Slug was enhanced in EGFRhigh/EpCAMlow HNSCC patients and correlated with reduced overall and disease‐free survival (OS, DFS) [11]. Here, MAPK3 is linked to head and neck squamous cell carcinoma.